Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A new implantable device can extract stem cells for therapeutic transplant or program cancer cells to die.
By monitoring the path of stem cells in the body, scientists can better explore experimental therapies, and doctors can better tune treatments in patients.
A new study reveals the influence of large RNA molecules in controlling stem cells.
A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.
Some diabetics who received a stem-cell transplant do not need insulin injections years later.